PDA

View Full Version : UFDA Approves Monthly Injectable Drug for Treating Three Types of Immune-Related Arth

News Reader
04-24-2009, 07:19 PM
The U.S. Food and Drug Administration today approved Simponi (golimumab), a monthly treatment for adults with moderate-to-severe rheumatoid arthritis, active psoriatic arthritis, and active ankylosing spondylitis.

More... (http://www.fda.gov/bbs/topics/NEWS/2009/NEW02000.html)